Renaissance Technologies (RenTech)'s BIOA Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC (Rentech)) currently holds 18,400 shares of BioAge Labs, Inc. (BIOA) worth $243,432, representing 0.00% of the portfolio. First purchased in 2025-Q2, this short-term holding has been held for 3 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained this position in BIOA for several quarters, showing initial confidence in the investment. Largest addition occurred in Q3 2025, adding 53,704 shares. Largest reduction occurred in Q4 2025, reducing 124,600 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s BioAge Labs (BIOA) Holding Value Over Time
Track share changes against reported price movement
Quarterly BioAge Labs (BIOA) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -124,600 | Reduce 87.13% | 18,400 | $13.23 |
| Q3 2025 | +53,704 | Add 60.14% | 143,000 | $5.88 |
| Q2 2025 | +89,296 | New Buy | 89,296 | $4.13 |
Renaissance Technologies (RenTech)'s BioAge Labs Investment FAQs
Renaissance Technologies (RenTech) first purchased BioAge Labs, Inc. (BIOA) in Q2 2025, acquiring 89,296 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held BioAge Labs, Inc. (BIOA) for 3 quarters since Q2 2025.
Renaissance Technologies (RenTech)'s largest addition to BioAge Labs, Inc. (BIOA) was in Q2 2025, adding 89,296 shares worth $368,792.
According to the latest 13F filing for Q4 2025, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC (Rentech), owns 18,400 shares of BioAge Labs, Inc. (BIOA), valued at approximately $243,432.
As of the Q4 2025 filing, BioAge Labs, Inc. (BIOA) represents approximately 0.00% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in BioAge Labs, Inc. (BIOA) was 143,000 shares, as reported at the end of Q3 2025.